Pharmaceutical market slows down growth pace

The pharmaceutical market in Romania advanced only 4 percent over the first three months of the year, after it had gone up 25 percent in Q1 2007, shows data with research company Cagedim.
The market continues its descending evolution started in middle of 2007, caused by the leu’s depreciation.
"We didn’t expect such evolution. We estimated a lower growth compared to 2007, but hope to recover towards year-end,” director of Centrofarm drugstores Dorin Catana told Ziarul Financiar.
The pharmaceutics market evolved from 1.56 billion lei in Q1 of 2007 to 1.62 billion lei in Q1 of 2008 (1 euro= 3.67 lei).
The sales of drugs in drugstores advanced 10.4 percent in Q1 2008, compensating for 25 percent decline in sales in hospitals. Some drugs previously included in national programmes were directed towards retail, which triggered this divergent evolution.
Leader on the Romanian market remains GlaxoSmithKline (continuing its drop in market share), followed by Novartis, Hoffman La Roche, Sanofi-Aventis, Servier, Pfizer, Ranbaxy, Zentiva, Antibiotice and KRKA D.D.
Citește și

Spune ce crezi

Adresa de email nu va fi publicata

Acest sit folosește Akismet pentru a reduce spamul. Află cum sunt procesate datele comentariilor tale.